IM Cannabis (IMCC) Change in Working Capital (2023 - 2025)
IM Cannabis' (IMCC) quarterly Change in Working Capital came in at -$12.4 million in Q4 2025, down 246.63% year-on-year from $8.5 million in Q4 2024, and down 363.91% quarter-over-quarter from $4.7 million in Q3 2025.
IM Cannabis (IMCC) Change in Working Capital (2023 - 2025) Analysis & Trends
IM Cannabis' Change in Working Capital history runs 3 years deep, the most recent figure standing at -$12.4 million for Q4 2025.
- On a quarterly basis, Change in Working Capital fell 246.63% year-over-year to -$12.4 million in Q4 2025; TTM through Dec 2025 was -$12.2 million, a 4.31% decrease from a year earlier, with the FY2025 full-year figure at -$5.6 million, down 198.99% from the prior year.
- Change in Working Capital fell to -$12.4 million in Q4 2025 per IMCC's latest filing, from $4.7 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $4.7 million in Q3 2025 and bottomed at -$12.4 million in Q4 2025.
- The 3-year median for Change in Working Capital is -$3.5 million (2024), against an average of -$3.2 million.
- Biggest YoY gain for Change in Working Capital was 593.86% in 2025; the steepest drop was 246.63% in 2025.
- Year by year, Change in Working Capital stood at -$3.5 million in 2023, then decreased by 1.7% to -$3.6 million in 2024, then sank by 246.63% to -$12.4 million in 2025.
- Per Business Quant, the three latest IMCC Change in Working Capital figures stand at -$12.4 million (Q4 2025), $4.7 million (Q3 2025), and -$3.6 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -617.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.39 Mn |
| Dec 31, 2025 | -12.39 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Dec 31, 2024 | -3.57 Mn |
| Dec 31, 2024 | -3.57 Mn |
| Sep 30, 2024 | -950,770.27 |
| Sep 30, 2024 | -950,770.27 |
| Jun 30, 2023 | -3.52 Mn |
| Jun 30, 2023 | -3.52 Mn |
| Mar 31, 2023 | -3.68 Mn |
| Mar 31, 2023 | -3.68 Mn |